Novel Tx for Resistant HIV Promising in Phase IIb/III Efficacy Study

(MedPage Today) -- Monoclonal antibody PRO 140 met primary efficacy endpoint
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Primary Care | Study